References
Kaplan JH, Lutsenko S (2009) Copper transport in mammalian cells: special care for a metal with special needs. J Biol Chem 284:25461–25465
Merle U, Tuma S, Herrmann T, Muntean V, Volkmann M, Gehrke SG, Stremmel W (2010) Evidence for a critical role of ceruloplasmin oxidase activity in iron metabolism of Wilson disease gene knockout mice. J Gastroenterol Hepatol 25:1144–1150
Turnlund JR (1998) Human whole-body copper metabolism. Am J Clin Nutr 67:960S–964S
Horslen SP, Tanner MS, Lyon TD, Fell GS, Lowry MF (1994) Copper associated childhood cirrhosis. Gut 35:1497–1500
Merli M, Patriarca M, Loudianos G, Valente C, Riggio O, De Felice G, Petrucci F, Caroli S, Attili AF (1998) Use of the stable isotope 65Cu test for the screening of Wilson’s disease in a family with two affected members. Ital J Gastroenterol Hepatol 30:270–275
Blower PJ, Lewis JS, Zweit J (1996) Copper radionuclides and radiopharmaceuticals in nuclear medicine. Nucl Med Biol 23:957–980
Bush JA, Mahoney JP, Markowitz H, Gubler CJ, Cartwright GE, Wintrobe MM (1955) Studies on copper metabolism. XIV. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration. J Clin Invest 34:1766–1778
Osborn SB, Szaz KF, Walshe JM (1969) Studies with radioactive copper (64Cu and 67Cu): abdominal scintiscans in patients with Wilson’s disease. Q J Med 38:467–474
Peng F, Lutsenko S, Sun X, Muzik O (2011) Positron emission tomography of copper metabolism in the Atp7b−/− knock-out mouse model of Wilson’s disease. Mol Imaging Biol (in press)
Scheinberg IH, Sternlieb I (1965) Wilson’s disease. Annu Rev Med 16:119–134
Gitlin JD (2003) Wilson disease. Gastroenterology 125:1868–1877
Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML (2007) Wilson’s disease. Lancet 369:397–408
Donsante A, Johnson P, Jansen LA, Kaler SG (2010) Somatic mosaicism in Menkes disease suggests choroid plexus-mediated copper transport to the developing brain. Am J Med Genet A 152A:2529–2534
Inoue K, Takano H, Shimada A, Satoh M (2009) Metallothionein as an anti-inflammatory mediator. Mediat Inflamm 2009:101659
Bohlken A, Cheung BB, Bell JL, Koach J, Smith S, Sekyere E, Thomas W, Norris M, Haber M, Lovejoy DB et al (2009) ATP7A is a novel target of retinoic acid receptor β2 in neuroblastoma cells. Br J Cancer 100:96–105
Furukawa T, Komatsu M, Ikeda R, Tsujikawa K, Akiyama S (2008) Copper transport systems are involved in multidrug resistance and drug transport. Curr Med Chem 15:3268–3278
Turski ML, Thiele DJ (2009) New roles for copper metabolism in cell proliferation, signaling, and disease. J Biol Chem 284:717–721
Gupte A, Mumper RJ (2009) Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev 35:32–46
Subramanian I, Vanek ZF, Bronstein JM (2002) Diagnosis and treatment of Wilson’s disease. Curr Neurol Neurosci Rep 2:317–323
Hancock CN, Stockwin LH, Han B, Divelbiss RD, Jun JH, Malhotra SV, Hollingshead MG, Newton DL (2011) A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo. Free Radic Biol Med 50:110–121
Acknowledgments
This work was supported in part by the Intramural Research Program (IRP) of the National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH, and the International Cooperative Program of the National Science Foundation of China (NSFC) (81028009).
Conflict of Interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, H., Chen, X. Visualization of Copper Metabolism by 64CuCl2-PET. Mol Imaging Biol 14, 14–16 (2012). https://doi.org/10.1007/s11307-011-0483-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-011-0483-5